BioElectronics Corporation announced that after seeking legal counsel a Board of Directors and Company officers have been appointed/re-affirmed. These changes follow the unexpected passing of the Company's founder, President and CEO Mr. Andrew Whelan, in October 2019. Pursuant to Section 2 of Article III of BioElectronics Corporation's Bylaws, and as a prior requirement that the Board of Directors shall constitute three (3) directors, the individuals identified below have been appointed as a Director of the Corporation, each to hold such position: Patricia A. Whelan: Chairman of the Board; Keith E. Nalepka: Executive Member; Kelly A. Whelan: Executive Member.

Further, pursuant to Section 1 and Section 9 of Article V of the Corporation's bylaws adopted on February 27, 2001 the Board of Directors has appointed the individuals identified below to the office opposite his/her name, each to hold such office until the next annual meeting of the Board and until his/her successor is elected and qualified, or until his/her earlier death, resignation or removal: John R. Martinez: Secretary; Vice President, Engineering; Keith E. Nalepka: Vice President, Sales; Kelly A. Whelan: Treasurer; President; Chief Executive Officer; Patricia A. Whelan: Chairman of the Board; Additionally, the individuals below have been engaged as consultants in a capacity opposite his/her name: Richard Staelin, Ph.D.: Marketing, Clinical and Statistical Research; Kenneth J. McLeod, Ph.D.: Clinical and Engineering Research.